Apart from stimulating immune responses via death-associated antigens, immunogenic cell death is accompanied by the release of diverse damage-associated molecular patterns (DAMPs), such as calreticulin (CRT), high mobility group protein 1 (HMGB1), adenosine triphosphate (ATP), heat shock proteins (HSPs), and others
In 2017, President Trump declared the opioid crisis a nationwide public health emergency

supports regrowth as the growth cycle restores Thinning hair and reduced hair density early to moderate loss of hair fullness across the scalp Excessive hair shedding reduces hair fall caused by weakened or inflamed follicles Follicle dormancy stimulates inactive follicles to re-enter the active growth phase Scalp inflammation reduces chronic inflammation that suppresses follicle function Poor hair strength and brittleness nourishes and strengthens fragile hair from the follicle level Diffuse hair loss improves overall scalp coverage and hair density across the treatment area To get the most from your treatment and minimise any risk of irritation, follow these guidelines in the days before your appointment: Avoid chemical hair treatments, including dyes and straightening treatments, in the lead-up to your session Avoid direct sun exposure, solariums, and sunbeds Avoid intensive cardio and gymnasium sessions on the day of treatment Avoid excessively hot showers, baths, spas, or saunas Avoid blood-thinning medications where possible consult your provider if you take aspirin, NSAIDs, or anticoagulants regularly Arrive with a clean, dry scalp, free of styling products and dry shampoo Please inform your provider of any medical conditions, scalp conditions, current medications, or known sensitivities before your first appointment

This tri-receptor activity profile is what separates it from earlier compounds like semaglutide (GLP-1 only) and tirzepatide (GLP-1/GIP), and is the basis for the significant fat loss results observed in Phase 2 clinical trials